Smart Wristband Health Monitoring: Powerful New Wearable Technology
Rutgers University engineers have developed a smart wristband health monitoring device that connects wirelessly to smartphones, enabling a new generation of personal health and environmental monitoring. The technology, detailed in Microsystems and Nanoengineering, goes well beyond existing wearables by incorporating a biosensor capable of counting blood cells, bacteria, and airborne particles. According to the Mayo Clinic, wearable health monitoring tools are becoming increasingly important for tracking health indicators outside of clinical settings.
What Makes This Smart Wristband Health Monitoring Device Different
Current wearables like fitness trackers can measure a limited set of physical parameters such as heart rate and activity levels. The Rutgers smart wristband health monitoring system goes significantly further. As lead author Abbas Furniturewalla, former undergraduate researcher in the Department of Electrical and Computer Engineering, explained, the ability for a wearable device to monitor counts of different cells in the bloodstream would take personal health monitoring to an entirely new level.
Senior author Mehdi Javanmard, assistant professor in the Department of Electrical and Computer Engineering, described it simply: it is like a fitness tracker but with a biosensor that can count particles, including blood cells, bacteria, and organic or inorganic particles in the air.
How the Technology Works
The smart wristband health monitoring device includes a flexible circuit board embedded in a plastic wristband. At its core is a biosensor with a channel thinner than the diameter of a human hair, with gold electrodes embedded inside. The device also contains a circuit to process electrical signals, a microcontroller for digitizing data, and a Bluetooth module for wireless transmission.
Blood samples are obtained through a simple pinprick, with blood fed through the biosensor channel and cells counted electronically. Data is transmitted wirelessly to an Android smartphone app that processes and displays results in real time. The technology is also compatible with iPhones and other smartphones, making it broadly accessible.
Why Smart Wristband Health Monitoring Matters for Clinical Research
In health care settings and in the field, this smart wristband health monitoring approach could allow health professionals to obtain rapid blood test results from patients without the need for expensive, bulky laboratory equipment. Blood cell counts are diagnostically significant across a wide range of conditions. Low red blood cell counts can indicate internal bleeding or anemia. Abnormally high or low white blood cell counts are associated with certain cancers including leukemia.
For clinical trial participants, especially those in communities located far from research sites, remote smart wristband health monitoring tools could meaningfully reduce the burden of participation. Continuous monitoring and remote data transmission to physicians could replace some in person visits entirely, improving data quality and participant retention simultaneously.
Environmental Applications Beyond Personal Health
The smart wristband health monitoring platform is not limited to blood analysis. The same particle counting technology can be applied to environmental monitoring, tracking exposure to air pollutants, dust, and other airborne particles over time. Workers in high exposure environments such as mining operations could use the device to measure the particles they encounter daily, generating the kind of longitudinal exposure data that is difficult to collect through any other means.
What Comes Next
As wearable biosensor technology continues to advance, smart wristband health monitoring devices like this one are positioned to become essential tools in both consumer health and clinical research. FOMAT actively monitors emerging technologies that have the potential to improve how clinical trials collect real time patient data and reach underserved communities.
FOMAT conducts Phase I through Phase IV clinical research across a national network of investigator sites throughout the United States. To learn more about active studies, visit our patient active studies page.